These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 18802115
1. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells. Nochi H, Tomura H, Tobo M, Tanaka N, Sato K, Shinozaki T, Kobayashi T, Takagishi K, Ohta H, Okajima F, Tamoto K. J Immunol; 2008 Oct 01; 181(7):5111-9. PubMed ID: 18802115 [Abstract] [Full Text] [Related]
2. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. Miyabe Y, Miyabe C, Iwai Y, Yokoyama W, Sekine C, Sugimoto K, Harigai M, Miyasaka M, Miyasaka N, Nanki T. Arthritis Res Ther; 2014 Oct 02; 16(5):461. PubMed ID: 25273676 [Abstract] [Full Text] [Related]
3. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS. Cell Signal; 2013 Nov 02; 25(11):2147-54. PubMed ID: 23838008 [Abstract] [Full Text] [Related]
4. Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Di Battista J, Clair T, Poubelle PE, Bourgoin SG. Mol Pharmacol; 2008 Feb 02; 73(2):587-600. PubMed ID: 18006645 [Abstract] [Full Text] [Related]
12. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Okajima F. Mol Pharmacol; 2003 Oct 01; 64(4):994-1005. PubMed ID: 14500756 [Abstract] [Full Text] [Related]
13. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Jüngel A, Distler O, Schulze-Horsel U, Huber LC, Ha HR, Simmen B, Kalden JR, Pisetsky DS, Gay S, Distler JH. Arthritis Rheum; 2007 Nov 01; 56(11):3564-74. PubMed ID: 17968936 [Abstract] [Full Text] [Related]
14. TNF-α potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts. Rodriguez Perez CE, Nie W, Sinnett-Smith J, Rozengurt E, Yoo J. Am J Physiol Gastrointest Liver Physiol; 2011 Apr 01; 300(4):G637-46. PubMed ID: 21292998 [Abstract] [Full Text] [Related]
15. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line. Zhang Z, Liu Z, Meier KE. Am J Physiol Cell Physiol; 2006 Nov 01; 291(5):C1089-98. PubMed ID: 16760261 [Abstract] [Full Text] [Related]
16. Involvement of prostaglandin E(2) in interleukin-1alpha-induced parathyroid hormone-related peptide production in synovial fibroblasts of patients with rheumatoid arthritis. Yoshida T, Sakamoto H, Horiuchi T, Yamamoto S, Suematsu A, Oda H, Koshihara Y. J Clin Endocrinol Metab; 2001 Jul 01; 86(7):3272-8. PubMed ID: 11443200 [Abstract] [Full Text] [Related]
17. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice. Park E, Kim D, Lee SM, Jun HS. Oncotarget; 2017 Apr 18; 8(16):27240-27251. PubMed ID: 28460477 [Abstract] [Full Text] [Related]
18. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inoue H, Takamori M, Nagata N, Nishikawa T, Oda H, Yamamoto S, Koshihara Y. Inflamm Res; 2001 Feb 18; 50(2):65-72. PubMed ID: 11289656 [Abstract] [Full Text] [Related]
19. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis. Orosa B, García S, Martínez P, González A, Gómez-Reino JJ, Conde C. Ann Rheum Dis; 2014 Jan 18; 73(1):298-305. PubMed ID: 23486415 [Abstract] [Full Text] [Related]
20. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice. Li HY, Oh YS, Choi JW, Jung JY, Jun HS. Kidney Int; 2017 Jun 18; 91(6):1362-1373. PubMed ID: 28111010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]